BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36505175)

  • 1. Importance of Low Pregnancy Associated Plasma Protein-A (PAPP-A) Levels During the First Trimester as a Predicting Factor for Adverse Pregnancy Outcomes: A Prospective Cohort Study of 2636 Pregnant Women.
    Papamichail M; Fasoulakis Z; Daskalakis G; Theodora M; Rodolakis A; Antsaklis P
    Cureus; 2022 Nov; 14(11):e31256. PubMed ID: 36505175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Da Silva AB; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):400-407. PubMed ID: 32441401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of low pregnancy associated plasma protein-A with increased umbilical artery pulsatility index in cases of fetal weight between the 3rd and 10th percentiles: a retrospective cohort study.
    Dias da Silva C; Sarmento Gonçalves I; Ramalho C
    J Perinat Med; 2024 Jan; 52(1):90-95. PubMed ID: 37853809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of β-human-derived chorionic gonadotrophic hormone (βhCG) and pregnancy-associated plasma protein A (PAPP-A) levels as predictive factors of preeclampsia in the first trimester among Iranian women: a cohort study.
    Honarjoo M; Kohan S; Zarean E; Tarrahi MJ
    BMC Pregnancy Childbirth; 2019 Dec; 19(1):464. PubMed ID: 31801467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine first-trimester combined screening for pre-eclampsia: pregnancy-associated plasma protein-A or placental growth factor?
    Noël L; Guy GP; Jones S; Forenc K; Buck E; Papageorghiou AT; Thilaganathan B
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):540-545. PubMed ID: 33998078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher PAPP-A Values in Pregnant Women Complicated with Preeclampsia Than with Gestational Hypertension.
    Uriel M; Romero Infante XC; Rincón Franco S; Ibáñez Pinilla EA; Rojas NA
    Reprod Sci; 2023 Aug; 30(8):2503-2511. PubMed ID: 36917422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obstetric Outcome in Pregnant Patients with Low Level of Pregnancy-Associated Plasma Protein A in First Trimester.
    Livrinova V; Petrov I; Samardziski I; Jovanovska V; Simeonova-Krstevska S; Todorovska I; Atanasova-Boshku A; Gjeorgjievska M
    Open Access Maced J Med Sci; 2018 Jun; 6(6):1028-1031. PubMed ID: 29983796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine first-trimester pre-eclampsia screening and risk of preterm birth.
    Giorgione V; Quintero Mendez O; Pinas A; Ansley W; Thilaganathan B
    Ultrasound Obstet Gynecol; 2022 Aug; 60(2):185-191. PubMed ID: 35441764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First trimester low maternal serum pregnancy associated plasma protein-A (PAPP-A) as a screening method for adverse pregnancy outcomes.
    Kantomaa T; Vääräsmäki M; Gissler M; Sairanen M; Nevalainen J
    J Perinat Med; 2023 May; 51(4):500-509. PubMed ID: 36131518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified multiple marker aneuploidy screening as a primary screening test for preeclampsia.
    Huang T; Bedford HM; Rashid S; Rasasakaram E; Priston M; Mak-Tam E; Gibbons C; Meschino WS; Cuckle H; Mei-Dan E
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):190. PubMed ID: 35260099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.
    Spencer K; Yu CK; Cowans NJ; Otigbah C; Nicolaides KH
    Prenat Diagn; 2005 Oct; 25(10):949-53. PubMed ID: 16086443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-trimester serum analytes, biophysical tests and the association with pathological morphometry in the placenta of pregnancies with preeclampsia and fetal growth restriction.
    Odibo AO; Zhong Y; Longtine M; Tuuli M; Odibo L; Cahill AG; Macones GA; Nelson DM
    Placenta; 2011 Apr; 32(4):333-8. PubMed ID: 21324404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.
    Birdir C; Droste L; Fox L; Frank M; Fryze J; Enekwe A; Köninger A; Kimmig R; Schmidt B; Gellhaus A
    Pregnancy Hypertens; 2018 Apr; 12():124-128. PubMed ID: 29674192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of Pregnancy-Associated Plasma Protein-A for Predicting Adverse Pregnancy Outcome.
    Mohamad Jafari R; Masihi S; Barati M; Maraghi E; Sheibani S; Sheikhvatan M
    Arch Iran Med; 2019 Oct; 22(10):584-587. PubMed ID: 31679360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of uterine artery Doppler in interpreting low PAPP-A values in first-trimester screening for Down syndrome in pregnancies at high risk of impaired placentation.
    Herraiz I; López-Jiménez EA; García-Burguillo A; Nieto O; Villar OP; Escribano D; Galindo A
    Ultrasound Obstet Gynecol; 2009 May; 33(5):518-23. PubMed ID: 19402101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome.
    Yaron Y; Heifetz S; Ochshorn Y; Lehavi O; Orr-Urtreger A
    Prenat Diagn; 2002 Sep; 22(9):778-82. PubMed ID: 12224070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for trisomy at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.
    Mazer Zumaeta A; Wright A; Syngelaki A; Maritsa VA; Bardani E; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):408-415. PubMed ID: 32621353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications.
    D'Antonio F; Rijo C; Thilaganathan B; Akolekar R; Khalil A; Papageourgiou A; Bhide A
    Prenat Diagn; 2013 Sep; 33(9):839-47. PubMed ID: 23613261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Placental Growth Factor and Adverse Obstetric Outcomes in a Mixed-Risk Cohort of Women Screened for Preeclampsia in the First Trimester of Pregnancy.
    Ekelund CK; Rode L; Tabor A; Hyett J; McLennan A
    Fetal Diagn Ther; 2021; 48(4):304-312. PubMed ID: 33789295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.